Filed before 2025Filed 26 December 2019
Entrada Therapeutics, Inc. has sold $34M so far
Entrada Therapeutics, Inc., a pharmaceuticals company based in Boston, MA, has sold $34M so far in its equity round, according to a filing dated 26 December 2019.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 26 December 2019
- First filed
- 26 December 2018
- Round
- Equity round (amended filing)
- Amount sold
- $34M
- Offering size
- $59M
- Investors so far
- 10
- Based in
- Boston, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
3 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 86% of the 1,781 tracked raises with an amount filed in 2019, and than 73% of the 33 in pharmaceuticals.
Entrada Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 13 Apr 2021 | New filing | $116M | Another raise |
| 26 Dec 2019 | Amended filing | $34M | This raise |
| 26 Dec 2018 | New filing | $34M | This raise |
More with 5AM Ventures on the board
- S2N Health Inc.$3M
- Ride Health, Inc.$15.5M
- Huma.AI, Inc.$1.02M
- Itiliti Health, Inc.$574K
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.